Evidence map›Paper›PMID 30952216›Full record

Trial reportJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2019

Circadian Preference as a Moderator of Depression Outcome Following Cognitive Behavioral Therapy for Insomnia Plus Antidepressant Medications: A Report From the TRIAD Study.

Lauren D Asarnow, Bei Bei, Andrew Krystal, Daniel J Buysse, Michael E Thase, Jack D Edinger, Rachel Manber

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Examining fronto-limbic brain and sleep mechanisms of antidepressant effects in cognitive-behavioral therapy for insomnia.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Trial
  3. Trial
  4. Trial
  5. An examination of chronotype associations with symptoms of depression, PTSD, and sleep disturbances in US military veterans.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026
    Article
  6. Article
  7. Review
  8. Role of chronotype in depression.World journal of psychiatry · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Patterns of sleep disturbances and associations with depressive symptoms in autistic young adults.Autism research : official journal of the International Society for Autism Research · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Sleep and Mood Disorders Among Youth.Child and adolescent psychiatric clinics of North America · 2021
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lauren D AsarnowDepartment of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, California.
Bei BeiMonash Institute of Cognitive and Clinical Neurosciences, School of Psychological Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Victoria, Australia.
Andrew KrystalSchool of Medicine, University of California, San Francisco, California.
Daniel J BuysseDepartment of Psychiatry, University of Pittsburgh, Pennsylvania.
Michael E ThaseDepartment of Psychiatry, University of Pittsburgh, Pennsylvania.
Jack D EdingerDepartment of Medicine, National Jewish Health, Denver, Colorado.
Rachel ManberDepartment of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, California.

Funding

Reducing Risk: A Comprehensive mHealth Sleep Health Intervention for Adolescents at Risk for Depression and Anxiety DisordersK23MH116520 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ASARNOW, LAUREN · 2018 to 2023
$854k
NIMH NIH HHS K23 MH116520
6 · The paper itself

Abstract

STUDY

objectivesWe previously presented results from a randomized controlled trial that examined the effects of antidepressant medication plus cognitive behavioral therapy for insomnia (CBT-I) among patients with major depressive disorder (MDD) and insomnia. The current secondary analysis aims to examine whether circadian preference moderated the reduction in depression and insomnia symptom severity during this trial.

methodsA total of 139 adult participants with MDD and insomnia disorder were treated with antidepressant medication and randomized to receive 7 sessions of CBT-I or a control therapy (CTRL). Circadian preference (eveningness) was measured using the Composite Scale of Morningness (CSM). Depression symptom severity was assessed using the Hamilton Depression Rating Scale (HDRS); insomnia symptom severity was assessed using the Insomnia Severity Inventory (ISI). The moderating role of circadian preference on changes in HRSD and ISI was assessed via latent growth models within the framework of structural equation modeling.

resultsGreater evening preference was associated with smaller reduction in HDRS (

conclusionsIndividuals with MDD and insomnia who have an evening preference are at increased risk for poor response to pharmacological depression treatment augmented with either CBT-I or CTRL behavioral insomnia treatment. However, evening types have better depression outcomes when treated with CBT-I than with CTRL for insomnia.

Indexed as

Circadian RhythmAdultAntidepressive AgentsCognitive Behavioral TherapyCombined Modality TherapyDepressionFemaleHumansMaleSleep Initiation and Maintenance DisordersTreatment OutcomeAntidepressive AgentsCBT-Icircadiandepressioneveningnessinsomnia

Identifiers

PMID30952216
PMCPMC6457514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.